Director's Updates about Alzheimers Disease

NIMH Perspective on Treating Alzheimer’s Patients with Antipsychotic Medications

October 12, 2006 • Director's Update
The recent publication of phase 1 results from the NIMH-funded Clinical Antipsychotic Trials in Intervention Effectiveness for Alzheimer's disease (CATIE-AD) in the New England Journal of Medicine provides new information about the use of several “atypical” antipsychotic medications for the treatment of psychotic symptoms in patients with Alzheimer's disease.

Footer

Some NIMH pages link to PDF files. Download Adobe Reader to view and print PDF files.

The National Institute of Mental Health (NIMH) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services.